Structural heart disease refers to a problem with the tissues or valves of the heart. Many structural heart conditions could be witnessed since birth, but some may develop later in life because of wear and tear from infection. There are various kinds of structural heart diseases such as aortic valve stenosis, heart valve disease, left ventricular hypertrophy, myocarditis, mitral valve regurgitation, and many more. Various symptoms differ depending upon the condition and the patient. Although, general symptoms include shortness of breath, chest pain, high blood pressure, and mini-strokes.
The "Global Structural Heart Disease Treatment Devices Professional Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the structural heart disease treatment devices professional market with detailed market segmentation by product, end user, and geography. The report provides key statistics on the market status of the leading structural heart disease treatment devices professional market players and offers key trends and opportunities in the market.
- Based on product, the global structural heart disease treatment devices professional market is segmented into replacement devices and repair devices.
- On the basis of end-users, the market is bifurcated into hospitals and clinics, ASCs.
- Increase in the prevalence of structural heart diseases such as congenital heart defects, aortic stenosis, and heart valve disease.
- Rise in the number of innovative product launches.
- Technological advancement in structural heart disease treatment.
- Increase in the number of M&A activities.
- Strong clinical pipeline for heart valve devices.
- The high price associated with structural heart disease treatment procedures
- Lack of skilled personnel.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The structural heart disease treatment devices professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the structural heart disease treatment devices professional market in these regions.
IMPACT OF COVID-19 ON STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic outbreak had significantly slowed down the growth of the market due to worldwide lockdown. The treatment of various diseases was delayed as the appointments were postponed and canceled. All the focus was shifted towards COVID-19 patients, affecting the market growth. Moreover, the outbreak has also disrupted the supply chain, restricted trade, thereby affecting the business and caused less demand for the product impacting the market growth. However, the market will experience growth after the removal of restrictive measures and companies resuming their operations and adapting to the new normal.
The report covers key developments in the structural heart disease treatment devices professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from structural heart disease treatment devices professional market are anticipated to have lucrative growth opportunities in the future with the rising demand for structural heart disease treatment devices professional in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the structural heart disease treatment devices professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Becton,Dickinson and Co.
- Braile Biomedica
- Boston Scientific Corp.
- CryoLife Inc.
- Edwards Lifesciences Corp.
- LivaNova Plc
- Lepu Medical Technology (Beijing) Co. Ltd.
- Medtronic Plc
- MicroPort Scientific Corp.